DGAP-News: Immunic, Inc.: Immunic Announces Start of Patient Cohorts in Its Phase 1 Clinical Trial of IMU-856 in Celiac Disease
Issuer: Immunic, Inc. / Key word(s): Study Immunic Announces Start of Patient Cohorts in Its Phase 1 Clinical Trial of IMU-856 in Celiac Disease 05.05.2022 / 12:30 The issuer is
Source: finanznachrichten.de